334 related articles for article (PubMed ID: 19688337)
1. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity.
Beck Jørgensen S; O'Neill HM; Hewitt K; Kemp BE; Steinberg GR
Diabetologia; 2009 Nov; 52(11):2395-404. PubMed ID: 19688337
[TBL] [Abstract][Full Text] [Related]
2. Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase-dependent pathway that is impaired with obesity.
Steinberg GR; Watt MJ; Ernst M; Birnbaum MJ; Kemp BE; Jørgensen SB
Diabetes; 2009 Apr; 58(4):829-39. PubMed ID: 19136654
[TBL] [Abstract][Full Text] [Related]
3. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice.
O'Neill HM; Lally JS; Galic S; Thomas M; Azizi PD; Fullerton MD; Smith BK; Pulinilkunnil T; Chen Z; Samaan MC; Jorgensen SB; Dyck JR; Holloway GP; Hawke TJ; van Denderen BJ; Kemp BE; Steinberg GR
Diabetologia; 2014 Aug; 57(8):1693-702. PubMed ID: 24913514
[TBL] [Abstract][Full Text] [Related]
4. AMPK and insulin action--responses to ageing and high fat diet.
Frøsig C; Jensen TE; Jeppesen J; Pehmøller C; Treebak JT; Maarbjerg SJ; Kristensen JM; Sylow L; Alsted TJ; Schjerling P; Kiens B; Wojtaszewski JF; Richter EA
PLoS One; 2013; 8(5):e62338. PubMed ID: 23671593
[TBL] [Abstract][Full Text] [Related]
5. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction.
Jensen TE; Rose AJ; Jørgensen SB; Brandt N; Schjerling P; Wojtaszewski JF; Richter EA
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1308-17. PubMed ID: 17213473
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification.
Tanaka T; Hidaka S; Masuzaki H; Yasue S; Minokoshi Y; Ebihara K; Chusho H; Ogawa Y; Toyoda T; Sato K; Miyanaga F; Fujimoto M; Tomita T; Kusakabe T; Kobayashi N; Tanioka H; Hayashi T; Hosoda K; Yoshimatsu H; Sakata T; Nakao K
Diabetes; 2005 Aug; 54(8):2365-74. PubMed ID: 16046303
[TBL] [Abstract][Full Text] [Related]
7. Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice.
Fujii N; Ho RC; Manabe Y; Jessen N; Toyoda T; Holland WL; Summers SA; Hirshman MF; Goodyear LJ
Diabetes; 2008 Nov; 57(11):2958-66. PubMed ID: 18728234
[TBL] [Abstract][Full Text] [Related]
8. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acetyl-CoA carboxylase 2 enhances skeletal muscle fatty acid oxidation and improves whole-body glucose homeostasis in db/db mice.
Glund S; Schoelch C; Thomas L; Niessen HG; Stiller D; Roth GJ; Neubauer H
Diabetologia; 2012 Jul; 55(7):2044-53. PubMed ID: 22532389
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle.
Saha AK; Xu XJ; Lawson E; Deoliveira R; Brandon AE; Kraegen EW; Ruderman NB
Diabetes; 2010 Oct; 59(10):2426-34. PubMed ID: 20682696
[TBL] [Abstract][Full Text] [Related]
11. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats.
Mullen KL; Pritchard J; Ritchie I; Snook LA; Chabowski A; Bonen A; Wright D; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R243-51. PubMed ID: 19073900
[TBL] [Abstract][Full Text] [Related]
13. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
[TBL] [Abstract][Full Text] [Related]
14. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
[TBL] [Abstract][Full Text] [Related]
15. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway.
Zhang C; McFarlane C; Lokireddy S; Bonala S; Ge X; Masuda S; Gluckman PD; Sharma M; Kambadur R
Diabetologia; 2011 Jun; 54(6):1491-501. PubMed ID: 21347623
[TBL] [Abstract][Full Text] [Related]
16. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
[TBL] [Abstract][Full Text] [Related]
17. Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance.
Holloway GP; Chou CJ; Lally J; Stellingwerff T; Maher AC; Gavrilova O; Haluzik M; Alkhateeb H; Reitman ML; Bonen A
Diabetologia; 2011 Jun; 54(6):1457-67. PubMed ID: 21442160
[TBL] [Abstract][Full Text] [Related]
18. The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice.
Marcinko K; Bujak AL; Lally JS; Ford RJ; Wong TH; Smith BK; Kemp BE; Jenkins Y; Li W; Kinsella TM; Hitoshi Y; Steinberg GR
Mol Metab; 2015 Sep; 4(9):643-51. PubMed ID: 26413470
[TBL] [Abstract][Full Text] [Related]
19. High-fat diet-induced impairment of skeletal muscle insulin sensitivity is not prevented by SIRT1 overexpression.
White AT; Philp A; Fridolfsson HN; Schilling JM; Murphy AN; Hamilton DL; McCurdy CE; Patel HH; Schenk S
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E764-72. PubMed ID: 25159328
[TBL] [Abstract][Full Text] [Related]
20. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle.
Taylor EB; An D; Kramer HF; Yu H; Fujii NL; Roeckl KS; Bowles N; Hirshman MF; Xie J; Feener EP; Goodyear LJ
J Biol Chem; 2008 Apr; 283(15):9787-96. PubMed ID: 18276596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
